Home › Funds › WASHINGTON GROWTH STRATEGIES LLC › MMED

WASHINGTON GROWTH STRATEGIES LLC position in MMED

MINIMED GROUP INC COM · Health Care

WASHINGTON GROWTH STRATEGIES LLC reported holding 26,587 shares of MMED (MINIMED GROUP INC COM) in its Q3 2026 13F filing — a position valued at US$518K, representing 0.28% of its reported portfolio and ranking #46 among its reported holdings. WASHINGTON GROWTH STRATEGIES LLC has disclosed MMED holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)26.59K sh
Reported value held$517.65K
Portfolio Weight0.28%
First reportedQ1 2026
Last changeHold
Updated2026-10-20

Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR

How WASHINGTON GROWTH STRATEGIES LLC's MMED position evolved

WASHINGTON GROWTH STRATEGIES LLC first disclosed a stake in MMED in Q1 2026 at 26,587 shares (US$397K). The position peaked in Q3 2026 at 26,587 shares, worth US$518K. Across 3 filings, WASHINGTON GROWTH STRATEGIES LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 26,587 shares valued at US$518K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 26.59K $396.68K New
Q2 2026 26.59K $397.48K Hold
Q3 2026 26.59K $517.65K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MMED and 13F data

MMED (MINIMED GROUP INC COM) is a Health Care company. 111 other funds we track also report a position in MMED — the largest reported positions include Longaeva Partners L.P. (US$42.1M), Sessa Capital IM, L.P. (US$29.9M), Rock Springs Capital Management LP (US$22.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MMED

All MMED fund holders →

FAQ

How long has WASHINGTON GROWTH STRATEGIES LLC held MMED?

WASHINGTON GROWTH STRATEGIES LLC has disclosed MMED holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is WASHINGTON GROWTH STRATEGIES LLC's current position in MMED?

As of Q3 2026, WASHINGTON GROWTH STRATEGIES LLC holds 26.59K shares of MMED (MINIMED GROUP INC COM), valued at $517.65K, representing 0.28% of its reported portfolio and ranking #46.

Has WASHINGTON GROWTH STRATEGIES LLC been buying or selling MMED?

In the latest 13F filing (Q3 2026), WASHINGTON GROWTH STRATEGIES LLC held unchanged its position in MMED. The position peaked in Q3 2026 at 26.59K shares.

Which other funds hold MMED?

Other major institutional holders of MMED include Longaeva Partners L.P., Sessa Capital IM, L.P., Rock Springs Capital Management LP, among 111 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.